Mr. Thomas Looby reports

CONAVI MEDICAL ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET

Conavi Medical Corp. has been approved for uplisting from the Pink Open Market to the OTCQB Venture Market, with trading set to commence on March 6, 2025. The ticker symbol will remain CNVIF, and no action is needed by shareholders. Trading on the OTCQB Venture Market is expected to complement the company's existing listing on the TSX Venture Exchange.

"As we move toward commercial launch of our next-generation Novasight system, we're pleased to increase investor transparency and visibility with this uplisting," said Thomas Looby, Conavi Medical's chief executive officer. "We believe this step will increase our exposure to the U.S. [United States] investment community and broaden our investor base."

Operated by OTC Markets Group Inc., the OTCQB Venture Market is a U.S. trading platform designed for developing and entrepreneurial-stage companies. The U.S. Securities and Exchange Commission considers the OTCQB Venture Market to be an established public market for determining the public market price when registering securities for resale. Companies listed on the OTCQB Venture Market are current in their reporting and undergo an annual verification and management certification process. Additional information about the OTC Markets Group and the OTCQB Venture Market can be found at the OTC Markets website.

About Conavi Medical Corp.

Conavi Medical is focused on designing, manufacturing and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid system is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. The Novasight Hybrid system has 510(k) clearance from the U.S. Food and Drug Administration, and regulatory approval for clinical use from Health Canada, China's National Medical Products Administration and Japan's Ministry of Health, Labor and Welfare.

We seek Safe Harbor.